Acyclovir in the treatment of hand-foot-and-mouth disease

Cutis

Volumn 57, Issue 4, 1996, Pages 232-234

  Shelley, Walter B ^a   Hashim, Mohammed ^b   Dorinda Shelley, E ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ERYTHROMYCIN;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXSACKIE VIRUS A; DRUG EFFICACY; FEMALE; HAND FOOT AND MOUTH DISEASE; HUMAN; INFANT; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; TREATMENT OUTCOME;

ACYCLOVIR; ADMINISTRATION, ORAL; ADULT; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HAND, FOOT AND MOUTH DISEASE; HUMANS; INFANT; MALE; TREATMENT OUTCOME;

EID: 0029873413     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Kane KS, Gellis SE, Johnson RA; Hand-foot-and-mouth disease. Fitzpatrick's J Clin Dermatol 3: 42-43, 1995.
2. Rocchi G, Volpi A: Mucocutaneous syndromes. In, Coxsackie Viruses: A General Update (Bendinelli M, Friedman H, eds), pp 339-349. New York, Plenum Press, 1988.
3. Burroughs Wellcome Co, Research Triangle Park, NC. Data on file.
4. Elion GB: Acyclovir: discovery, mechanisms of action and selectivity. J Med Virol 1: 2-6, 1993 (Suppl).
5. Stenseth AM, Rollag H, Degré M: Effect of in vitro acyclovir treatment on selected functions of blood-derived macrophages. Chemotherapy 39: 197-202, 1993.
6. Vlach J, Pitha PM: Differential contribution of herpes simplex virus type I gene products and cellular factors to the activation of human immunodeficiency virus type I provirus. J Virol 67: 4427-4431, 1993.
7. Schalm SW, Heytink RA, van Buuren HR, et al: Acyclovir enhances the anti-viral effect of Interferon in chronic hepatitis B. Lancet 346: 358-360, 1985.